Matrix Capital Management Exits Aura Biosciences with $39M Share Repurchase

summarizeSummary

Aura Biosciences completed a $39 million share repurchase from Matrix Capital Management, marking the investment firm's full exit as a shareholder.

check_boxKey Events

• Major Share Repurchase Completed

  Aura Biosciences repurchased 6,922,870 shares of common stock from Matrix Capital Management Company LP at $5.64 per share, totaling approximately $39.04 million. This transaction was completed on May 7, 2026, following a definitive agreement announced on May 4, 2026.

• Significant Investor Exits

  Matrix Capital Management Company LP, a former 10% owner, has fully divested its stake in Aura Biosciences. This Schedule 13D/A serves as an "exit filing" for the reporting persons, indicating they no longer hold any shares.

auto_awesomeAnalysis

This filing confirms the completion of Aura Biosciences' repurchase of 6.92 million shares from Matrix Capital Management Company LP for $39 million. This transaction, previously announced in an 8-K on May 4, 2026, marks the complete exit of Matrix Capital Management as a significant shareholder. The repurchase reduces the outstanding share count and follows recent capital raises, indicating the company's active capital management.